Synthetic products derived from cannabis, opioids and cathinones with effects similar to amphetamines are gaining ground in the EU, warned the European Union Drugs Agency (EUDA) on Thursday 5 June in its new 2025 edition on drug use in the EU.
The Agency also warns that rapid changes in the European medicines market are generating new health and safety risks and putting the region’s response capacity to the test.
It has identified 7,500 drug-related deaths in 2023, compared with 7,100...